News
Kierland Commons Accelerates Leasing Momentum with Exciting Retail Additions
FOR IMMEDIATE RELEASE MEDIA CONTACTJammel SinghMarketing Manager, Kierland Commonsjammel.singh@macerich.com915.727.0228 Kierland Commons Accelerates Leasing Momentum with Exciting Retail AdditionsKiehl’s, Warby Parker, Beyond Yoga and More to Open This Year SCOTTSDALE, AZ., March 5, 2026 – Kierland Commons continues its strong leasing momentum in 2026 with the addition of three highly recognized brands and the relocation of a growing retailer.Kiehl’s Since
_(1).jpg)
Mayo Clinic Opens Healthcare Store
Mayo Clinic Opens Healthcare Store PHOENIX — Mayo Clinic has opened the Mayo Clinic Store, expanding access to personalized healthcare products and services for people managing complex medical conditions, recovery, and daily living challenges across Phoenix, Scottsdale, and surrounding communities. Unlike traditional medical supply retailers, the Mayo Clinic Store is designed around individualized care. The location offers private, confidential consultations with trained professionals, including
Credit Union West Appoints Jeff Lee as Chief Lending Officer
Glendale, AZ — Credit Union West announced the appointment of Jeff Lee as Chief Lending Officer, effective March 9. Lee brings extensive executive experience across consumer, mortgage, commercial, and business financing, along with a strong track record of building high-performing teams and delivering exceptional member experiences. Lee joins Credit Union West following senior leadership roles at TruWest Credit Union, where he led strategic growth initiatives and enhanced solutions designed to expand
Cortexa Therapeutics Advances Target Validation as Phase 1b and Phase 2 Research Progress
FOR IMMEDIATE RELEASE Cortexa Therapeutics Advances Target Validation as Phase 1b and Phase 2 Research Progress Phoenix, Arizona – February 16, 2026 – Cortexa Therapeutics, Inc. today announced significant progress in its scientific validation roadmap, with Phase 1b and Phase 2 studies currently underway in collaboration with its contract research organization (CRO) partner in Scotland. These phases represent a critical advancement in validating Cortexa’s biological target and strengthening the
